T 0795/13 (Modified glycoproteins/GLYCOFI) 10-01-2019
Download and more information:
Methods for producing modified glycoproteins
Glycode
Novartis AG
I. The appeal of the patent proprietor (appellant) lies from a decision of an opposition division posted on 21 December 2012, revoking the European patent No. 1 522 590 (application No. 04025648.9) with the title "Methods for producing modified glycoproteins".
II. By a communication pursuant to Rule 84(1) EPC dated 6 July 2018, the board informed the parties that, even though the European patent had lapsed with effect for all the designated Contracting States, the appeal proceedings could be continued at their request, provided that the request was filed within two months from notification of the communication.
III. Following a failure to notify opponent 1 (respondent I), the communication was re-sent to responent I on 12 October 2018.
IV. No request for continuation of the proceedings was received from any of the parties.
1. Pursuant to Rule 84(1) EPC in conjunction with Rule 100(1) EPC, appeal proceedings may be continued after the European patent has lapsed, if the opponent files a request to this effect within two months of a communication informing him of the lapse (see, inter alia, decisions T 329/88 of 22 June 1993; T 949/09 of 17 October 2012; and T 480/13 of 5 November 2014).
2. According to the jurisprudence of the Boards of Appeal (see, e.g., decision T 520/10 of 11 June 2013), when the patent proprietor has filed an appeal, by analogy to Rule 84(1) in connection with Rule 100(1) EPC the appeal proceedings may be continued also upon request of the patent proprietor.
3. Since no request for continuation of the appeal proceedings was received from any of the parties in due time, the board decides to terminate the appeal proceedings.
For these reasons it is decided that:
The appeal proceedings are terminated.